Profitelligence Profitelligence · Filing Ledger Open WAT research →

Form 8-K · Current Report · Filed 2025-05-29

Waters Corporation Amends Credit Agreement

On May 22, 2025, Waters Corporation amended its credit agreement to remove its existing term loan facility of up to $200 million and retained its senior unsecured revolving credit facility of up to $1.8 billion, maturing on May 22, 2030, with potential for a one-year extension.

Filer
Waters Corporation WAT · NYSE
Filed
Accession
0001193125-25-130641
CIK
0001000697
Signal
Medium impactHealthcare

Details

The Company may also request additional commitments up to $750 million, subject to lender discretion. Interest rates and facility fees vary based on leverage ratios and credit ratings. The Company can use the revolving facility for general corporate purposes and has the right to prepay without penalties. The Amendment contains covenants and representations, warranties, and events of default.

Items reported

Item 1.01

Entry into a Material Definitive Agreement

Financial Instrument Agreement
Item 2.03

Creation of a Direct Financial Obligation

Credit Facility Entered
Item 9.01

Financial Statements and Exhibits

No viable tag

Market reaction

Close before filing

$354.59

Next session

-1.5%

Since filing

+6.4%

Latest close

$377.31

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from WAT reporting the same item, with the next session's move:

Exhibits (1)

About Waters Corporation

Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another WAT filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts